/f/288104308443570/4176x1488/0b1865ffdf/telemedizin-web.png)
Hybrid Care Pathways
We are looking for solutions that continue to accompany patients digitally after discharge via telemonitoring and telemedicine in order to ensure seamless care from the hospital to the home, detect complications at an early stage, and reduce avoidable inpatient readmissions.
Hybrid Care Pathways
We are looking for solutions that continue to accompany patients digitally after discharge via telemonitoring and telemedicine in order to ensure seamless care from the hospital to the home, detect complications at an early stage, and reduce avoidable inpatient readmissions.
Key Challenge Partner
Our hub partner UKGM is under considerable capacity pressure, similar to many other hospitals. The demand for inpatient care in Germany is rising, and the clinic wishes to provide patients with safe outpatient or home-based care instead of inpatient admission—specifically through digital continued accompaniment, known as Hospital at Home. So far, however, the technical foundation for this is lacking because vital signs recorded at home find no connection to clinical systems. The consequences are avoidable readmissions, which drive up costs and block urgently needed capacities.
Final Blueprint
Patients are accompanied digitally during their treatment and / or after their discharge. Vital signs flow directly from home into the hospital, and anomalies trigger an early alarm. Hybrid Care Pathways connect the hospital, home, and aftercare: from acute care and rehabilitation to the long-term management of chronic diseases.
Industry Bottlenecks
Patients fall into a care vacuum after discharge.
General practitioners are becoming fewer, home visits hardly take place anymore, and nursing homes are underserved.
The recording of vital signs at home is not compatible with hospital systems.
Readmissions drive up costs and block beds for other patients.
Why founders choose LOVEDIS
Our ecosystem gives you real connections, lab space, and industrial infrastructure to test what you’ve built. We bridge the gap between ideas and implementation so you can grow faster and with less risk.
Direct access to industry
Work with partners who open doors to infrastructure, expertise, and real use cases, accelerating your path toward market readiness.
Access to real resources
Labs, workshops, machinery, network, data, and operational setups - it’s all here. Use what you need to validate and scale faster.
Equity-Free & Zero Cost
Our program is free of charge, and we take no equity.
Tailored 1-to-1 support
No copy-paste coaching. Individual mentoring and support that makes real progress possible.
Application form
Apply now
Applications close on May 3, 2026
Any questions?
If you have any questions or need clarification, please reach out directly to our Venture & Innovation Manager, Polina.
/f/288104308443570/3393x3399/21f8af7c71/polina-kon-lovedis.png)
Challenges in Health Tech
Haven’t found the right fit yet? Explore more of our health tech challenges below.
/f/288104308443570/1634x1956/d6afffeb9c/challenge1.png)
Digital Initial Assessment and Patient Steering
We are looking for solutions that digitally capture patients even before their hospital visit, assess them medically, and route them systematically into the appropriate care structure.
FAQs
Find answers to the most common questions about our program and application process.
No. Participation in LOVEDIS is free for startups — including access to infrastructures, expert teams, and program resources.
Our program is two-tiered and results-driven. All teams begin with the three-month Base Accelerator. High-performing teams then qualify for the subsequent 1:1 Accelerator, where we spend an additional three months working intensively and individually on your scaling strategy.
Yes — if you are a tech startup with a prototype or MVP and a clear goal to validate or scale together with industry partners.
The Base Accelerator works well in a hybrid format. The 1:1 Accelerator includes on-site phases with our hub partners to validate and develop your solution in real environments.
We focus on teams beyond the pure idea stage. You should have a prototype, MVP, or early product that can be tested, validated, and further developed with partners.
No. Incorporation is not required for application. A GmbH or similar structure is helpful later — but not a condition to enter the program.
Yes. We welcome European and international teams — as long as they’re willing to collaborate with our industry and hub partners.
We focus on technologies with strong industrial relevance, particularly in LifeScience, Construction, and Industry & Automation. Cross-industry solutions are explicitly welcome.
No — LOVEDIS does not take equity.